Pharmacokinetics of liposomal amphotericin B in neutropenic cancer patients

Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia

Thomas J. Walsh, Robert W. Finberg, Carola Arndt et al. · New England Journal of Medicine · 1999 · 1.2K citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patients

Olle Ringdén, F. Meunier, J Tollemar et al. · Journal of Antimicrobial Chemotherapy · 1991 · 281 citations

Medicine, Infectious Diseases, Pharmacology +17

Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial

F. Meunier, H. G. Prentice, Olle Ringdén · Journal of Antimicrobial Chemotherapy · 1991 · 248 citations

Pharmacy, Pharmacology, Pharmacotherapy +7

Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents

Richard T. Proffitt, A. Satorius, S.-M. Chiang et al. · Journal of Antimicrobial Chemotherapy · 1991 · 202 citations

Pharmacy, Pharmacology, Toxicology +15

Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes

Philippe Legrand, Eneida A. Romero, Benjamin E. Cohen et al. · Antimicrobial Agents and Chemotherapy · 1992 · 199 citations · Full text

Pharmacy, Biochemistry, Toxicology +14